London R&D Companies Directory

The Cell and Gene Therapy Catapult is a not-for-profit organisation established to accelerate the development and commercialisation of advanced therapy medicinal products (ATMPs) in the UK. They provide infrastructure, technical expertise, and collaborative platforms to bridge the gap between academic research and industrial manufacturing. Their work has evolved from foundational process development to leading large-scale national networks for regulatory innovation, robotic automation, and sustainable manufacturing.

Digital Catapult is the UK's leading agency for accelerating the adoption of advanced digital technologies across industry. They bridge the gap between research and commercialisation by facilitating collaborative R&D, providing testbed infrastructure, and running innovation programmes that connect startups with large enterprise challenge owners. Their work spans artificial intelligence, immersive technologies, digital twins, and quantum computing, aimed at driving productivity and economic growth across the UK economy.

Imperial College London is a world-leading research-intensive university that operates as a major hub for translational R&D across engineering, medicine, and physical sciences. Through its extensive grant history, the institution collaborates with industry partners to develop advanced technologies in areas such as sustainable energy, medical diagnostics, additive manufacturing, and aerospace engineering. Its work consistently bridges the gap between fundamental scientific discovery and practical industrial application, often serving as the academic anchor in large-scale innovation consortia.

University College London (UCL) is a world-leading multidisciplinary research university that engages in extensive collaborative R&D across diverse sectors including MedTech, AI, and Clean Energy. Through its grant history, the institution has evolved from fundamental academic research into a key partner for commercialisation, frequently acting as the technical engine for industry-led consortia. Their work spans from developing advanced quantum computing and medical diagnostics to pioneering net-zero building technologies and carbon capture solutions.

Brunel University London is a research-intensive academic institution that serves as a critical hub for collaborative industrial R&D across the UK. Their work spans advanced manufacturing, sustainable materials, clean energy, and artificial intelligence, frequently partnering with SMEs and large industry players to translate academic research into practical, net-zero-aligned solutions. They act as a key technical partner in complex consortia, providing expertise in structural engineering, material science, and digital process optimisation.

King's College London is a world-leading academic institution that conducts extensive interdisciplinary research across medical, digital, and social sciences. Their grant history demonstrates a strong focus on translating fundamental research into real-world applications, particularly in AI-driven healthcare, neurotechnology, cybersecurity, and democratic governance. The university frequently collaborates with NHS trusts, industrial partners, and international consortia to address complex societal challenges through rigorous scientific and policy-oriented innovation.

The Knowledge Transfer Network (KTN), now Innovate UK Business Connect, is a public sector research establishment that facilitates cross-sector collaboration to accelerate innovation. They operate as a national intermediary, connecting businesses, academics, and government bodies to foster knowledge exchange across diverse technology domains. Their work focuses on managing complex innovation programmes, scoping international research opportunities, and driving strategic partnerships to address global challenges.

Spirit Aerosystems is a major aerospace manufacturer specialising in the design, development, and high-rate production of complex aerostructures, particularly composite wings and nacelles. Their work focuses on industrialising advanced manufacturing processes, such as out-of-autoclave composite fabrication and automated assembly, to improve production efficiency and reduce costs for large-scale aircraft programmes. Recently, the company has expanded its technical scope to include sustainable manufacturing methods and liquid hydrogen storage integration for future zero-emission flight.

Eni is a multinational energy company that leverages its extensive expertise in oil and gas exploration and production to drive large-scale industrial decarbonisation projects in the UK. The company plays a critical role in developing infrastructure for Carbon Capture, Utilisation and Storage (CCUS) and hydrogen production, focusing on the transformation of energy-intensive industrial clusters into Net Zero hubs. Their work involves complex cross-industry collaborations to integrate offshore storage systems with onshore industrial capture technologies.

Newable Limited is a large-scale business support organisation that delivers critical advisory, investment, and internationalisation services to UK SMEs. Through extensive partnerships with Innovate UK and other public bodies, the company facilitates business growth, innovation readiness, and global market access across diverse sectors. Their work focuses on scaling high-potential enterprises by providing expert guidance, investment support, and strategic connectivity.

Queen Mary University of London is a leading research-intensive university that leverages its multidisciplinary expertise to drive innovation across healthcare, artificial intelligence, and advanced materials. Their grant portfolio demonstrates a strong focus on translational research, bridging the gap between fundamental academic discovery and commercial application through strategic industry partnerships and Knowledge Transfer Partnerships. Their work has evolved from foundational scientific studies to complex, AI-driven solutions for medical diagnostics, sustainable energy, and industrial process optimisation.

The Cell and Gene Therapy Catapult is a specialist organisation established to accelerate the development and commercialisation of advanced therapy medicinal products in the UK. They provide critical infrastructure, manufacturing expertise, and coordination services to bridge the gap between laboratory research and clinical adoption. Their work focuses on building the industrial ecosystem required to deliver cell and gene therapies to patients at scale.

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in oncology, rare diseases, and biopharmaceuticals. Their grant history demonstrates a strategic shift toward digital transformation, sustainable manufacturing, and advanced predictive modelling to improve drug efficacy and environmental impact. They frequently collaborate with academic institutions and specialist technology partners to integrate robotics, AI, and genomic sequencing into their R&D and production pipelines.

The University of Greenwich is a research-intensive academic institution that leverages interdisciplinary expertise to address complex global challenges in agriculture, cybersecurity, and advanced manufacturing. Their work spans from fundamental research to applied innovation, frequently collaborating with industry partners to translate scientific breakthroughs into practical, sustainable solutions. The university maintains a diverse R&D portfolio, integrating digital technologies, AI, and material science to drive progress across sectors including MedTech, AgriTech, and Defence.

The University of Essex is a leading academic institution that leverages its research expertise to drive innovation through Knowledge Transfer Partnerships (KTPs). The university collaborates with a diverse range of commercial and third-sector partners to apply advanced technologies, including artificial intelligence, machine learning, and robotics, to real-world operational challenges. Their work spans multiple domains, from precision medicine and agricultural science to industrial automation and financial process optimisation.